IRIS
CASCELLA, TERESA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 567
EU - Europa 258
AS - Asia 164
AF - Africa 12
Totale 1.001
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 557
CN - Cina 83
SG - Singapore 72
IT - Italia 58
NL - Olanda 44
DE - Germania 39
SE - Svezia 38
IE - Irlanda 26
FI - Finlandia 25
UA - Ucraina 17
CI - Costa d'Avorio 12
CA - Canada 10
GB - Regno Unito 8
IN - India 8
BE - Belgio 1
ES - Italia 1
PH - Filippine 1
PL - Polonia 1
Totale 1.001
Salva come PNG Salva come JPEG
Città #
Chandler 137
Singapore 59
Amsterdam 43
Jacksonville 38
Millbury 38
Naples 37
Princeton 30
Wilmington 23
Nanjing 22
Beijing 21
Santa Clara 17
Ashburn 14
Boston 10
Nanchang 10
Woodbridge 10
Boardman 6
Ottawa 5
Des Moines 4
Hebei 4
Jiaxing 4
Seattle 4
Shenyang 4
Toronto 4
Changsha 3
Falls Church 3
Heidelberg 3
Kronberg 3
Norwalk 3
Pune 3
Redwood City 3
Shanghai 3
Washington 3
Dublin 2
Enterprise 2
Indiana 2
Lanzhou 2
Los Angeles 2
Monfalcone 2
Tappahannock 2
Tianjin 2
Ahmedabad 1
Ann Arbor 1
Bangalore 1
Brussels 1
Dallas 1
Dearborn 1
Delhi 1
Frankfurt am Main 1
Jining 1
Kolkata 1
Kumar 1
Kunming 1
London 1
Madrid 1
Marano 1
Munich 1
Napoli 1
New York 1
Regensburg 1
San Diego 1
Sandston 1
Shijiazhuang 1
Simi Valley 1
Warsaw 1
Yellow Springs 1
Totale 612
Salva come PNG Salva come JPEG
Nome #
Lack of electrocardiographic changes in women with polycystic ovary syndrome. 67
Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women. 64
Cardiopulmonary impairment in young women with polycystic ovary syndrome 56
Effects of neridronate treatment in elderly women with osteoporosis 51
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study 44
Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome 40
Aldosterone enhances IGF-I-mediated signaling and biological function in vascular smooth muscle cells. 38
Cardiovascular complications of obesity in adolescents 37
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 37
GH and IGF-I deficiency are associated with reduced loss of fat mass after laparoscopic-adjustable silicone gastric banding 36
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 36
The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. 34
Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women 34
Circulating ghrelin concentrations in the polycystic ovary syndrome 34
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study 34
Evidence for altered adipocyte function in polycystic ovary syndrome 33
Adiponectin levels in women with polycystic ovary syndrome 32
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: Results of a 6-month study 32
Endothelial dysfunction in PCOS: role of obesity and adipose hormones 31
Genetic analysis of the follicle stimulating hormone receptor gene in women with polycystic ovary syndrome. 30
Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome 29
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome 29
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome 28
Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects. 24
Lack of an association between peroxisome proliferator-activated receptor-γ gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome 24
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 24
Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome 24
Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome 21
Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas 19
Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas 13
Totale 1.035
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.330
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.330
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202055 0 0 0 0 7 0 2 0 0 10 12 24
2020/202154 1 4 9 4 4 14 7 1 4 1 4 1
2021/2022217 1 0 0 5 5 31 2 9 24 17 47 76
2022/2023280 34 30 12 27 35 29 0 15 38 45 11 4
2023/2024165 4 28 48 8 8 10 0 19 2 2 23 13
2024/2025111 29 41 2 17 22 0 0 0 0 0 0 0
Totale 1.035